#MondayNightIBD Aline Charabaty, MD, FACG, AGAF AbbVie JanssenUS Ferring Pharmaceuticals Takeda 56 yo M, #BMI of 54, Hyperlipidemia, Pan-UC, LOR to IFX due to anti-drug antibodies, now symptomatic on vedo Q 4 weeks. Albumin 3.2. Flex Sig: Mayo 3 left sided colitis. What's the best next option?

Freddy Caldera, DO, PhD Aline Charabaty, MD, FACG, AGAF Poonam Beniwal-Patel, MD #MondayNightIBD AbbVie JanssenUS Ferring Pharmaceuticals Takeda Nature Reviews Gastroenterology & Hepatology Parambir Dulai Sonia Ramamoorthy, MD FACS FASCRS Edward Loftus Joshua M. Steinberg, MD Waseem Ahmed @laura_targownik Parakkal Deepak MD, MS, FACG Price Edwards Brigid Boland Amanda Johnson, MD Sunanda Kane M.D. Shrinivas Bishu The risk of CV disease in JAK inhibitors is controversial Hyperlipidemia might have to be factored in. Although lipid abnormalities trend back to baseline over time. pubmed.ncbi.nlm.nih.gov/32870265/ Poonam Beniwal-Patel, MD Aline Charabaty, MD, FACG, AGAF Freddy Caldera, DO, PhD Edward Loftus

Great thread

Join Daniel J. Stein from Medical College of Wisconsin TOMORROW 🗓️ 5/1 for #MondayNightIBD ‼️ Come learn about #SmallBowel #Crohns management 📝🤓 #IBD #GITwitter #IBDTwitter MCW IM Chief Residents #MondayNightIBD

#GITwitter Join us now for a convo w Daniel J. Stein Aline Charabaty, MD, FACG, AGAF 🎯How do you approach Recurrent/Refractory/Progressive SB stricturing #Crohns 🗳️#IBDPoll👇🏽,RT & Share your 💬 ! 🆓#CME👉🏼bit.ly/3k6SHG8 Supported by educational grants @AbbVie Takeda

#MondayNightIBD Aline Charabaty, MD, FACG, AGAF AbbVie Takeda Gursimran Kochhar MD Gaurav Syal, MD MHDS Florian Rieder Sara El Ouali MD Ben Click Stefan Holubar MD MS David M. Schwartzberg, MD Dominik Bettenworth Jason Schairer Jean-Paul Achkar 32 w SB #Crohns x15yrs, ICR + jejunal✂️for sympt strictures 3 yrs ago. Presents w SBO, CT: jejunal🔥->IV steroids+ started IFX 10mg/kg. 4mos later: Wt loss, abdo pain, melena. Hgb 6,CRP nl, IFX 10. CT: SBO, jejunal thickening, ⬇️🔥. Not better on IV steroids x48hrs. What's next?

#MondayNightIBD Aline Charabaty, MD, FACG, AGAF AbbVie Takeda Gursimran Kochhar MD Gaurav Syal, MD MHDS Florian Rieder Sara El Ouali MD Ben Click Stefan Holubar MD MS David M. Schwartzberg, MD Dominik Bettenworth Jason Schairer Jean-Paul Achkar Active UGI bleeding a concern here. Have people seen this in #crohns patients and what’s it from? Where are my MCW/UW peeps? Amar S. Naik, MD Poonam Beniwal-Patel, MD Freddy Caldera, DO, PhD Preetika Sinh MD

Daniel J. Stein #MondayNightIBD Aline Charabaty, MD, FACG, AGAF AbbVie Takeda Gursimran Kochhar MD Gaurav Syal, MD MHDS Florian Rieder Sara El Ouali MD Ben Click Stefan Holubar MD MS David M. Schwartzberg, MD Dominik Bettenworth Jason Schairer Jean-Paul Achkar Nutrition is also a huge part of managing this case. Depending upon how much weight he has lost and how little he is eating, may need to start TPN. This would also help optimize nutritional status if he needs surgery.

#MondayNightIBD Aline Charabaty, MD, FACG, AGAF AbbVie Takeda Gursimran Kochhar MD Gaurav Syal, MD MHDS Florian Rieder Sara El Ouali MD Ben Click Stefan Holubar MD MS David M. Schwartzberg, MD Dominik Bettenworth Jason Schairer Jean-Paul Achkar Thread 1/4 NL CRP,⬇️🔥 on CT 🚫 response to IV steroids🟰fibrotic stricture. CT angiography neg.. Enteroscopy not attempted d/t dilated SB.  ALSO phenotype change: melena and weight loss raised 🚩🚩. So ✂️ and found to have jejunal adenoCA, 🚫nodes or metz.

#MondayNightIBD Aline Charabaty, MD, FACG, AGAF AbbVie Takeda Gursimran Kochhar MD Gaurav Syal, MD MHDS Florian Rieder Sara El Ouali MD Ben Click Stefan Holubar MD MS David M. Schwartzberg, MD Dominik Bettenworth Jason Schairer Jean-Paul Achkar Thread 2/4 Key points: Need to consider SB ACA in CD pt with change in phenotype. Crohn's about 10Xs gen pop for SB ACA.  RFs: ♂️, young age at Dx, long disease duration, multiple resections, diverted bowel, immunosuppressive use. All of which our patient had.

#IBDMasterClass Northwestern Medicine Jami Kinnucan, MD, FACG, AGAF, FCCF 💎Who is NOT a good candidate for #IBD therapy de-escalation? 📸 👇🏽 💎#DrKinnucan shares her ✅ list when having this convo w the patient 📝 👇🏽 DrShahidaDin Peter Higgins

Some of our star fellows killing it Digestive Disease Week Gta Kostenlos #MCWFellows #MedicalCollegeofWisconsin Freddy Pagani

Dr. Subra Kugathasan Genetics and #IBD at Medical College of Wisconsin Crohn's & Colitis Foundation Patient and Provider Conference. Whole genome sequencing will be a game changer for the future of #CrohnsDisease therapy

Dr. Carrie Peterson from MCW Surgery talking about when to call your colorectal surgeon in #IBD #Crohns #ulcerativecolitis

2023 Sherman Emerging Leader Prize Recipient, Andres Yarur, MD, is revolutionizing IBD care. His research on visceral fat's impact on IBD meds, and projects like ATLAS and CONSTELLATION, emphasize the need for tailored treatments. Dive into his groundbreaking work:Sherman Prize

Milwaukee GI Society IBD Debate MCW fellows 🤝 Aurora Fellows “Medical vs surgical management of a complex UC patient” Excellent debate by both teams moderated by Sumona Saha, MD and Poonam Beniwal-Patel, MD, proud of our 2nd year GI fellows Judie Hoilat and Mary Nemer! #MCWGI #IBD

Congratulations to our fellows and faculty on being awarded the Edmund M. Barbour, MD, Endowed Research Fellowship in Gastroenterology Fund for their research! We look forward to the impact of their work! #MCWGI

MCW Gastroenterology and Hepatology past and current fellows coming together at Digestive Disease Week! 🙌 #MCWatDDW #DDW2025

First year of GI fellowship ✅ ✨ Honored to receive the Dodds-Shaker Research Excellence Award 🎓 Congratulations to the graduating class of 2025! #WomenInGI #MCWGI